Disclosed is a use of a composition containing an iron (II) amino acidchelate used in the preparation of a drug for ameliorating diabetes, whereinthedrug comprises an effective dose of a composition containing an iron (II)amino acid chelate for ameliorating diabetes and a pharmaceutically acceptablecarrier thereof.